Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients

Abstract

Conversion from calcineurin inhibitor (CNI) to mTOR inhibitors may reduce and even halt the progression of chronic allograft dysfunction (CAD) which is the most important cause of renal allograft loss. We aimed to investigate the effects of conversion from CNI to everolimus on parameters of fibrosis, inflammation, glomerulotubular damage and vascular functions in renal transplant recipients. Fifteen stable renal transplant recipients who were under CNI treatment (male/female 13/2, mean age 41 +/- A 10 years) were enrolled and switched to everolimus. Serum and urinary transforming growth factor-beta (TGF-beta), urinary neutrophil gelatinase-associated lipocalin (NGAL) and monocyte chemoattractant protein-1 (MCP-1) were measured as markers of fibrosis, tubular damage and inflammation. As parameters of vascular functions, pulse wave velocity (PWV), augmentation index (AIx), serum asymmetric dimethyl-arginine and fibroblast growth factor-23 (FGF-23) were measured. All these measurements were repeated at the 3rd month of conversion. Estimated GFR (52 +/- A 7-57 +/- A 11 ml/min/l.73 m(2), p = 0.02) (was increased after conversion to everolimus. However, serum uric acid levels were significantly decreased (6.21 +/- A 1.21-5.50 +/- A 1.39 mg/dL, p = 0.01). Serum TGF-beta levels (8727 +/- A 2897-1943 +/- A 365 pg/mL, p = 0.03) and urinary NGAL levels (26 +/- A 10-12 +/- A 2 ng/mg creatinine, p = 0.05) were significantly decreased. However, urinary MCP-1, FGF-23, PWV and AIx did not change. Urinary TGF-beta was associated with urinary NGAL (r = 0.62, p = 0.01), urinary MCP-1 (r = 0.68, p = 0.005) and proteinuria (r = 0.50, p = 0.05). Conversion from CNI to everolimus resulted in significant decreases of serum TGF-beta and urinary NGAL which may represent less fibrosis and tubular damage. Association of urinary TGF-beta with NGAL and MCP-1 suggests that tubular damage, fibrosis and inflammation may act together for progression of CAD.